Literature DB >> 20691575

C-reactive protein does not impair insulin suppression of glucose release in primary hepatocytes.

F Ellis1, A Nivala, K T Pfaffenbach, C L Gentile, D Wang, Y Wei, M J Pagliassotti.   

Abstract

Recent studies have suggested that CRP may interfere with insulin signaling in skeletal muscle and endothelial cells. The aim of this study was to determine whether highly purified CRP increased the rate of glucose appearance in primary hepatocytes in the absence or presence of insulin. Primary rat hepatocytes were provided glucose-free media containing 10 mM lactate, 1 mM pyruvate, 0, 1 or 10 nM insulin, and 0 or 10 μg/ml of purified CRP for 6h. Purified CRP did not increase glucose release in the absence of insulin and did not reduce the ability of insulin to suppress glucose release.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691575      PMCID: PMC2978270          DOI: 10.1016/j.numecd.2010.04.013

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  25 in total

1.  Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor kappa b pathway.

Authors:  Carl F Raetzsch; Natasha L Brooks; J McKee Alderman; Kelli S Moore; Peter A Hosick; Simon Klebanov; Shizuo Akira; James E Bear; Albert S Baldwin; Nigel Mackman; Terry P Combs
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

2.  Elevated basal PI 3-kinase activity and reduced insulin signaling in sucrose-induced hepatic insulin resistance.

Authors:  Michael J Pagliassotti; Jione Kang; Jeffrey S Thresher; Chin K Sung; Michael E Bizeau
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-01       Impact factor: 4.310

3.  Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians.

Authors:  N G Forouhi; N Sattar; P M McKeigue
Journal:  Int J Obes Relat Metab Disord       Date:  2001-09

Review 4.  Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.

Authors:  David Preiss; Naveed Sattar
Journal:  Clin Sci (Lond)       Date:  2008-09       Impact factor: 6.124

5.  High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population.

Authors:  Tomomi Kogiso; Yuriko Moriyoshi; Satoru Shimizu; Hikaru Nagahara; Keiko Shiratori
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

Review 6.  Insulin resistance, inflammation, and non-alcoholic fatty liver disease.

Authors:  Herbert Tilg; Alexander R Moschen
Journal:  Trends Endocrinol Metab       Date:  2008-10-17       Impact factor: 12.015

7.  Association among C-reactive protein, Fatty liver disease, and cardiovascular risk.

Authors:  Javier Lizardi-Cervera; Norberto C Chavez-Tapia; Oliver Pérez-Bautista; Martha H Ramos; Misael Uribe
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

8.  Association of adiposity, inflammation and atherosclerosis: the role of adipocytokines and CRP in Asian Indian subjects.

Authors:  Sujata R Mahadik; Sudha S Deo; Suresh D Mehtalia
Journal:  Metab Syndr Relat Disord       Date:  2008-06       Impact factor: 1.894

9.  Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics.

Authors:  Arnoldo Riquelme; Marco Arrese; Alejandro Soza; Arturo Morales; René Baudrand; Rosa María Pérez-Ayuso; Robinson González; Manuel Alvarez; Verónica Hernández; María José García-Zattera; Francisco Otarola; Brenda Medina; Attilio Rigotti; Juan Francisco Miquel; Guillermo Marshall; Flavio Nervi
Journal:  Liver Int       Date:  2008-07-16       Impact factor: 5.828

Review 10.  CRP and the risk of atherosclerotic events.

Authors:  Paolo Calabrò; Enrica Golia; Edward T H Yeh
Journal:  Semin Immunopathol       Date:  2009-05-05       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.